The oligosaccharyltransferase complex catalyzes the transfer of oligosaccharide from a dolichol pyrophosphate donor en bloc onto a free asparagine residue of a newly synthesized nascent chain during the translocation in the endoplasmic reticulum lumen. The role of the less known oligosaccharyltransferase (OST) subunits, DC2 and KCP2, recently identified still remains to be determined. Here, we have studied DC2 and KCP2, and we have established that DC2 and KCP2 are substrate-specific, affecting amyloid precursor protein (APP), indicating that they are not core components required for N-glycosylation and OST activity per se. We show for the first time that DC2 and KCP2 depletion affects APP processing, leading to an accumulation of C-terminal fragments, both C99 and C83, and a reduction in full-length mature APP. This reduction in mature APP levels was not due to a block in secretion because the levels of sAPP␣ secreted into the media were unaffected. We discover that DC2 and KCP2 depletion affects only the ␥-secretase complex, resulting in a reduction of the PS1 active fragment blocking A production. Conversely, we show that the overexpression of DC2 and KCP2 causes an increase in the active ␥-secretase complex, particularly the N-terminal fragment of PS1 that is generated by endoproteolysis, leading to a stimulation of A production upon overexpression of DC2 and KCP2. Our findings reveal that components of the OST complex for the first time can interact with the ␥-secretase and affect the APP processing pathway.
Alzheimer disease (AD)2 is the primary cause of adult onset dementia, with a dramatic increase in the incidence of AD apparent in our aging population. AD is pathologically characterized by the accumulation of tangles and senile plaques. Senile plaques are composed of the amyloid- (A) peptides, A40 and A42 (1). The early onset familial form of AD is linked to three genes, amyloid precursor protein (APP) and presenilin (PS1 and PS2) (2, 3), strongly suggesting that the production of A is a key factor in the pathogenesis of AD. A is generated by proteolysis of APP, driven by the secretases found in the cell. Prior to proteolysis, APP undergoes a number of post-translational modifications, including N-glycosylation in the endoplasmic reticulum (ER) and O-glycosylation in the Golgi apparatus. In order to generate A40 and A42, APP is first cleaved by -secretase and then by ␥-secretase. For the cleavage of APP, -secretase competes with ␣-secretase, which produces non-amyloidogenic peptides (4). ␥-Secretase is an aspartyl protease complex composed of four core components, including presenilins (PS1/PS2), presenilin enhancer 2 (PEN2), nicastrin, and anterior pharynx-defective 1 (APH1) (2). Presenilin is the catalytic core of the ␥-secretase complex consisting of nine transmembrane domains (5) and is cleaved by an unknown protease called "presenilinase" or self-cleavage stimulated by PEN2 binding of the cytosolic loop between transmembrane domains 6 and 7, releasing N-and C-terminal PS1 fragments, th...